Ph3Responsibilities /h3ullibAsset-Level Medical Strategy Execution: /b Develop and implement the Global Medical Affairs plan for Ilumetri aligned with the biologics portfolio strategy, with emphasis on post‑launch lifecycle optimization; ensure tactical execution of medical plans within agreed global priorities and governance frameworks. /lilibScientific Evidence Excellence: /b Execute asset‑level evidence activities focused on evidence maturation, comparative positioning and long‑term value demonstration, aligned with portfolio‑level IEGP and RWE strategies; lead scientific exchange, publications and data dissemination to reinforce Ilumetri’s established profile. /lilibCross‑Functional Collaboration: /b Collaborate with RD, Market Access, Commercial, Regulatory and Global RWE teams to support sustained value, access and differentiation; contribute Ilumetri‑specific medical insights to general forums via the VP Global Medical Affairs, Biologics. /lilibGlobal‑to‑Local Enablement: /b Enable affiliates through clear lifecycle strategy, tools and guidance to ensure consistent and compliant medical execution; support quality, continuity and efficiency across global and local medical activities. /lilibPeople Leadership Development: /b Lead and develop the Global Medical Affairs Ilumetri team; promote stable performance, collaboration and capability development aligned with portfolio priorities. /li /ulh3Qualifications /h3ulliEducation: Degree in Medicine, Pharmacy, Biology, Chemistry or an equivalent scientific discipline; advanced degree (MD, PhD) is a plus. /liliLanguage: Fluent in English. /liliSpecific Knowledge: Experience in Medical Affairs for biologics, preferably in dermatology and immunology products in launch and mature stages; strong scientific background and medical communication skills; good understanding of integral medical governance and lifecycle management. /liliProfessional Experience: More than 10 years in Medical Affairs within pharma or biotech; experience working at the global level within a matrix organization; demonstrated people leadership and asset ownership experience. /li /ul /p #J-18808-Ljbffr